Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 3
2009 1
2010 3
2011 2
2012 1
2013 7
2014 4
2015 6
2016 5
2017 9
2018 6
2019 12
2020 20
2021 24
2022 20
2023 16
2024 12
2025 18
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept Trial.
Griesel R, Nuñez SA, Cordova E, Pérez Rios AM, Ridilenir VL, Lehmann C, Slim J, Arenzana CB, Szabo J, Cahn P, Post FA, Pierce A, Pestrak M, Jeffrey JL, Thakkar N, Shepherd B, Bainbridge V, Angelis K, McMillan C, Benn P. Griesel R, et al. Among authors: lehmann c. Clin Infect Dis. 2026 Jul 29:ciag452. doi: 10.1093/cid/ciag452. Online ahead of print. Clin Infect Dis. 2026. PMID: 42525562 Free article.
CD4+ cell count trends after common cancers in people with HIV: a multicohort collaboration.
Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Borges A, El-Sadr W, Lundgren J, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongui A, Young LA, Peters L, Ryom L; D:A:D, RESPOND Study Groups. Timiryasova A, et al. Among authors: lehmann c. AIDS. 2026 Jul 7. doi: 10.1097/QAD.0000000000004579. Online ahead of print. AIDS. 2026. PMID: 42412402
Characterization of post-COVID syndrome by self-perceived symptom severity stratified by infection wave: beyond COVID, a prospective, multicenter cohort study in Germany.
Mertens A, Smith J, Bergs I, Fischer J, Jansen S, Breitschwerdt S, Pracht E, Killer A, Schipper L, Kuklik N, Frank M, Schwichtenberg J, Bührmann S, Zeissler L, Dreher M, Rockstroh J, Rohn H, Lehmann C, Tepasse PR, Schmidt B, Dragano N, Bode J, Luedde T, Jensen BE; Beyond COVID Study Group. Mertens A, et al. Among authors: lehmann c. Infection. 2026 May 18. doi: 10.1007/s15010-026-02819-6. Online ahead of print. Infection. 2026. PMID: 42149360
A Prospective Incidence Study on Sexually Transmitted Infections and HIV in Men Who Have Sex With Men, With or Without Use of Pre-exposure Prophylaxis.
Jansen K, Crowell TA, Ottensmeyer PF, Esber AL, Steffen G, Jessen HK, Cordes C, Scholten S, Schneeweiss S, Brockmeyer NH, Spinner CD, Bickel M, Esser S, Baumgarten A, Stoehr A, Lehmann C, Vehreschild JJ, Mebrahtu T, Dorsey-Spitz J, Knorr A, Brillen AL, Pusnik J, Tiemann C, Michael NL, Robb ML, Streeck H. Jansen K, et al. Among authors: lehmann c. Open Forum Infect Dis. 2026 Apr 11;13(5):ofag205. doi: 10.1093/ofid/ofag205. eCollection 2026 May. Open Forum Infect Dis. 2026. PMID: 42057809 Free PMC article.
Long-term trends in Post-COVID severity: a machine learning analysis from the POP/COVIDOM cohort of the German NAPKON Cohort Network.
Gutzeit J, Weiß M, Bahmer T, Lieb W, Schreiber S, Vehreschild JJ, Nürnberger C, Pütz SM, Heim E, Ruß AK, Dempfle A, Krawczak M, Poick S, Schäfer A, Morbach C, Lehmann C, Polidori MC, Reese JP, Zoller T, Krist L, Heyckendorf J, Reinke LM, Deckert J, Hein G; NAPKON Study Group. Gutzeit J, et al. Among authors: lehmann c. EClinicalMedicine. 2026 Mar 10;93:103822. doi: 10.1016/j.eclinm.2026.103822. eCollection 2026 Mar. EClinicalMedicine. 2026. PMID: 41852926 Free PMC article.
Persistent Gut-Immune Axis dysregulation in long-term Post-COVID Syndrome: Insights from a prospective, observational, cross-sectional case-control study.
Augustin M, Picard L, Rauschning D, Zenev E, Pracht E, de Silva US, Heyn F, Ball M, Rostocki I, Herzog G, Dumoulin FL, Lin TH, Kirschner H, Petschnak S, Heger E, Fumero EF, Albert MC, Walczak H, Stingl M, Födinger M, Theobald SJ, Zoufaly A, Wenisch C, Rybniker J, Lehmann C. Augustin M, et al. Among authors: lehmann c. Mucosal Immunol. 2026 Jun;19(3):100328. doi: 10.1016/j.mucimm.2026.03.002. Epub 2026 Mar 5. Mucosal Immunol. 2026. PMID: 41794369 Free article.
Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.
Fisher K, Garcia MA, Frattari GS, Naasz C, Zhuo J, Rosás-Umbert M, Dietz LL, Juhl AK, Falling Iversen E, Olesen R, Schleimann MH, Pahus MH, Johansen IS, Henderson M, Carrere L, Roseto I, Gao C, Yu XG, Fray EJ, Aydin B, Lubbeck D, Lai J, Simonetti FR, Danesh A, Miller I, Mendoza P, Niessl J, Gaebler C, Seaman MS, Kaufmann DE, Lehmann C, Gruell H, Klein F, Caskey M, Nussenzweig MC, Tolstrup M, Jones RB, Gunst JD, Siliciano JD, Lichterfeld M, Siliciano RF, Søgaard OS. Fisher K, et al. Among authors: lehmann c. Nat Immunol. 2026 Apr;27(4):812-826. doi: 10.1038/s41590-026-02448-z. Epub 2026 Mar 3. Nat Immunol. 2026. PMID: 41776101 Free PMC article.
Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration.
Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Bonnet F, Lundgren J, Bottanelli M, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongiu A, Young LA, Peters L, Ryom L, On Behalf Of The D A D And Respond Study Groups. Timiryasova A, et al. Among authors: lehmann c. Cancers (Basel). 2025 Dec 16;17(24):4000. doi: 10.3390/cancers17244000. Cancers (Basel). 2025. PMID: 41463249 Free PMC article.
168 results